|
HS Code |
184002 |
| Organism Name | Methanosarcina acetivorans |
| Domain | Archaea |
| Cell Shape | Coccoid |
| Motility | Non-motile |
| Metabolism | Methanogenic |
| Energy Source | Acetate, methanol, methylamines |
| Genome Size Mbp | 5.75 |
| Optimal Temperature C | 37 |
| Gram Stain | Gram-negative |
| Habitat | Marine and freshwater sediments |
As an accredited Methanosarcina Acetivorans factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed sterile vial containing 5 mL of freeze-dried *Methanosarcina acetivorans* culture, labeled with strain details, lot number, and storage instructions. |
| Shipping | Methanosarcina acetivorans is shipped as a lyophilized culture or in sealed anaerobic containers to maintain viability. Packaging ensures protection from oxygen exposure and temperature fluctuations, often using insulated materials and cold packs. Shipments comply with biosafety guidelines for non-pathogenic microorganisms and include detailed handling and storage instructions. |
| Storage | **Methanosarcina acetivorans** should be stored in tightly sealed, sterile containers under anaerobic (oxygen-free) conditions to maintain viability. The recommended temperature for storage is typically −80°C for long-term preservation, often as cell suspensions in cryoprotectants such as glycerol. Regular monitoring is advised to ensure culture integrity and prevent contamination. Suitable labeling and recordkeeping are essential for traceability. |
|
Purity 99%: Methanosarcina Acetivorans with purity 99% is used in anaerobic digestion systems, where it enhances biogas yield and methane concentration. Thermal stability up to 80°C: Methanosarcina Acetivorans with thermal stability up to 80°C is used in high-temperature bioreactors, where it maintains metabolic activity for consistent methane production. Cell density 1.2 g/L: Methanosarcina Acetivorans at cell density 1.2 g/L is used in industrial wastewater treatment, where it accelerates organic matter degradation and reduces chemical oxygen demand. Doubling time 8 hours: Methanosarcina Acetivorans with a doubling time of 8 hours is used in pilot-scale bioconversion processes, where it supports rapid biomass accumulation and higher process throughput. Salinity tolerance 2.5% NaCl: Methanosarcina Acetivorans with salinity tolerance of 2.5% NaCl is used in saline waste treatment, where it ensures stable methane generation under high salt conditions. pH range 6.5–8.5: Methanosarcina Acetivorans with pH range 6.5–8.5 is used in municipal solid waste digestion, where it provides robust performance despite variable feedstock acidity. Acetate conversion efficiency 92%: Methanosarcina Acetivorans with acetate conversion efficiency 92% is used in fermentative hydrogen production systems, where it maximizes substrate utilization and gas output. Genomic stability >99%: Methanosarcina Acetivorans with genomic stability greater than 99% is used in continuous culture operations, where it ensures reliable phenotype retention and process reproducibility. |
Competitive Methanosarcina Acetivorans prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every day in our laboratories, Methanosarcina acetivorans delivers performance that matters to operations counting on consistency. This organism is one of the most versatile methanogenic archaea available for biotechnological use. Its metabolic flexibility sets it apart from the pack. Years of working hands-on with M. acetivorans cultures in biogas research, wastewater remediation, and synthetic biology have revealed both its promise and the careful approach needed to harness it efficiently at commercial scale.
Methanosarcina acetivorans belongs to the domain Archaea, a group well-known for their resilience in extreme environments. Unlike most methanogens, this microbe handles a broad selection of substrates: acetate, methanol, methylamines, and carbon monoxide, all feed directly into its pathways for methane generation. That broad input range translates to value in fermentation setups where waste stream composition changes over time—a real-world challenge for any operator trying to steady methane output.
Labs have developed and optimized several strains of M. acetivorans, including the well-characterized C2A model. In manufacturing, workhorse strains typically feature adaptations for both fast methylotrophic metabolism and improved growth at modest salinity. Unlike pure acetoclastic methanogens such as Methanosaeta, Methanosarcina acetivorans maximizes methane output from methanol or methylamines. In our experience, this versatility solves supply-chain issues for feedstock sourcing, especially when commodity prices shift or residues from multiple food-processing plants supply a digester.
Cells form irregular clumps rather than filaments, which simplifies separation and harvesting. The cell surface characteristics and aggregate size also help the organism withstand shifts in osmotic conditions. Industrial bioreactors benefit from this, since salt concentrations and minor impurities fluctuate during large-scale digestion. Standard production batches yield dense cultures with uniform performance, thanks to close control of pH, nutrient balance, and temperature—within the range of 30°C to 40°C.
Long-term production runs have made it clear: Methanosarcina acetivorans tolerates chemical and environmental variance better than narrow substrate specialists. Facilities extracting bioenergy from municipal and food industry waste streams report fewer production drops and process interruptions after switching to M. acetivorans-based systems. Its resilience under exposure to ammonia, sulfide, and certain trace metals—levels that often inhibit other methanogens—supports year-round operation without the constant micronutrient balancing demanded by other archaea.
Our teams learned early on that gas composition monitoring for hydrogen, carbon dioxide, and trace methane precursors keeps fermentations running smoothly. Operators accustomed to other cultures will notice that Methanosarcina acetivorans grows faster than Methanosaeta but slightly slower than Methanobacterium on rich methyl substrates. Productivity must be weighed against substrate cost and system resilience.
Methanosarcina acetivorans powers reactors digesting food waste, dairy residue, ethanol production leftovers, and high-strength industrial effluents. The list includes municipal solid waste digesters, landfill leachate systems, and pilot plants turning CO into methane via synthetic biology. Established customers see value in lower feedstock pretreatment costs and higher methane yields from unpredictable input streams.
For high-ammonia systems—dairy or protein-rich waste, for example—Methanosarcina acetivorans’ unique cell envelope and enzymatic machinery provide superior stability. Sites struggling to keep regular acetoclastic archaea alive during ammonium surges switched to our strains and nearly eliminated volatility in biogas output.
Performance on methanol, trimethylamine, and dimethylamine stands out. Methanosarcina acetivorans efficiently converts cheap, widely available methanol or distillery side-streams directly to methane. This capability supports novel process schemes: integrated biofuel complexes recover more energy, and chemical plants close the loop on emissions while producing pipeline-grade renewable natural gas (RNG).
On the factory floor or in the field, Methanosarcina acetivorans outpaces many classic methanogens in real, mixed waste compounds. Methanosaeta excels at pure acetate conversion but fails to match the overall methane output when methanol and methylamines come into play. Methanobacterium and Methanococcus handle hydrogen-fed routes but depend on costly process hydrogen, which limits their advantage. Mixed substrate streams favor M. acetivorans because it rapidly cycles between acetoclastic and methylotrophic modes, smoothing out daily feedstock variations.
Adaptation runs deeper than metabolic range. M. acetivorans recovers faster after disturbances. A sudden salt spike or souring event derails many archaea communities, forcing weekslong recovery. By contrast, M. acetivorans returns to previous productivity within days; process logs show stable methane production after brine spills, in digesters with regular pH fluctuations, and even during moderate temperature dips.
Its genomic complexity underpins this flexibility. Technicians working with model C2A or closely related strains have sequenced pathways not found in other archaea, boosting gene-editing options. Scientists exploring gene knockouts or new biosynthetic modules often pick Methanosarcina acetivorans as a platform. The organism carries extra gene clusters for methylamine utilization, stress response, and alternative energy generation.
Implementing Methanosarcina acetivorans at industrial sites begins with equipment familiarization. Typical starter cultures arrive fresh or lyophilized, ready for expansion in anaerobic media. Incorporation into continuous stirred-tank reactors or upflow anaerobic sludge blanket (UASB) systems proceeds without unusual inoculum requirements. During scale-up, careful nitrogen and trace metal supplementation supports rapid biomass accumulation. Our on-site teams advise keeping mixing gentle to maintain aggregate structure.
Routine maintenance includes substrate monitoring—not just acetate, but methanol and methylamines, which feed into parallel metabolic routes. Each parameter yields early warning on process drift, letting intervention occur before output drops. Operating at neutral to mildly alkaline pH. M. acetivorans offers an operational window that overlaps existing infrastructure built for sulfate reducers and classic methanogens, minimizing retrofit costs.
Biofilm formation presents a unique opportunity. Unlike planktonic cells, Methanosarcina acetivorans develops robust biofilms on carrier materials like expanded clay, plastics, or stainless steel mesh. These biofilms withstand washout, promoting reactor stability and allowing higher loading rates. Plants aiming for high throughput with shorter hydraulic retention time tap into this property for more compact reactor footprints.
Stricter emissions regulations and rising landfill diversion targets make unconventional waste streams more attractive for methane recovery. Methanosarcina acetivorans’ ability to process volatile fatty acids, methanol, methylamines, and CO means operators no longer limit their feedstock range to “easy” materials. This broadens both feedstock contracts and the revenue side of the RNG business. Plants integrating carbon capture and utilization (CCU) have reported that M. acetivorans performs repeatedly in setups capturing and converting off-gas CO.
Our engineers encountered regulatory staff who scrutinize microbial cultures for potential gene transfer or containment risks. Genomic studies show that M. acetivorans produces few mobile genetic elements and poses no risk for pathogenicity or toxin production, making it a reliable choice for large-scale, publicly regulated bioenergy installations. Results from independent labs echo our experience: once established, M. acetivorans populations maintain genetic stability for years.
Collaborative research with universities has produced new M. acetivorans variants with increased tolerance to high-salt and high-ammonia conditions. Labs report that modified strains handle up to twice the ammonium load of standard wild types. On the production side, we assess every batch for predictable growth, methane output, and aggregate size. Engineers compare each new culture against performance in mixed, real-world feedstock conditions, ensuring that custom variants deliver more than just improved laboratory numbers.
Pilot plants built for joint ventures highlight the organism’s adaptability. Waste-to-biogas projects seeking to upgrade landfill gas or turn brewery residues into RNG use Methanosarcina acetivorans as a foundation. Its rapid adaptation even under fluctuating feed rates makes it popular for demonstration projects, where investor confidence rides on achieving stable, repeatable methane production from heterogeneous input.
Methanosarcina acetivorans solves several persistent problems for plant operators. Research and feedback from waste treatment facilities indicate three main areas where this archaea shines: shifting substrate availability, moderate toxicity, and temperature or pH swings. In every case, operators report substantial cost savings on chemical correction, nutrient additives, or wasted downtime. That success translates into faster time-to-methane during commissioning and a more predictable operating horizon.
pH buffering with basic minerals or sodium carbonate accommodates the organism’s mild alkaliphily. For salinity jumps, feeding with diluted process water helps maintain aggregate integrity, avoiding system washout. When periodic ammonia spikes threaten conventional acetoclastic cultures, Methanosarcina acetivorans handles up to 1.2 g/L ammonium, where other strains crash below 500 mg/L. Sites with unpredictable inflow chemistry cite this trait as reason enough for switching.
Methanogenesis from carbon monoxide represents a recently industrialized pathway. Synthetic biologists working on power-to-gas and carbon recycling report that M. acetivorans uniquely expresses a carbon monoxide dehydrogenase capable of sustained methane production from pure CO. Commercial pilot units now validate that this archaea completes the process at rates and yields compatible with energy grid injection standards.
Methanosarcina acetivorans changes process economics by reducing feedstock pretreatment, avoiding expensive micronutrient balancing, and handling inconsistent waste streams. That impact extends to food processors aiming for zero waste and landfill operators transforming leachate or off-gas into value instead of expense. RNG producers benefit most, integrating M. acetivorans into hybrid biogas systems that handle wide substrate swings and deliver consistent output to the pipeline segment.
The organism’s flexibility shapes new business models for municipalities, food industry partners, and non-traditional waste managers. Thanks to ongoing improvements through genetic and process engineering, Methanosarcina acetivorans will likely support expanded methane recovery and carbon-neutral bioenergy generation over the next decade. We see a strong future for products and applications based on this remarkable archaea.
Over years of scaling up production, our teams have learned simple practices that unlock Methanosarcina acetivorans’ full potential. Consistent inoculum health checks prevent culture drift. Regular feedstock sampling and early corrective action turn potential production disruptions into minor fluctuations. Keeping maintenance routines tight, focusing on both nutrient quality and system hygiene, extends reactor lifespans and slashes unnecessary capital spending.
Methanosarcina acetivorans shines when leveraged by experienced hands. New operators find themselves adapting within a few production cycles. Over time, it builds confidence—process upsets that forced shutdowns in rival systems, now handled with in-line corrections rather than costly interventions. Our ongoing dialogue with customers, researchers, and regulatory partners continues to build best practices for this unique industrial microbe.
Methanosarcina acetivorans stands as one of the most reliable biological platforms for modern methane generation. Its ability to consistently deliver performance, whether in conventional digesters, power-to-gas units, or hybrid systems, established it as a cornerstone biotechnology for our own operations and for the broader energy, waste, and chemical industries. With robust field support and a strong record of adaptability, our manufacturing teams look forward to helping even more operations thrive using this versatile and time-tested organism.